← All trials
NCT04253262
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2020
- Primary completion
- Jan 31, 2021
- Completion date
- Jan 31, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 44
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Brown UniversityLead sponsor
- Clovis OncologyCollaborator
- BayerCollaborator
- Brown UniversityCollaborator
- Brown UniversityOverall official - principal investigator
- Brown UniversityReponsible party - principal investigator
- Rhode Island HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.